Potent inhibition of necroptosis by simultaneously targeting multiple effectors of the pathway

CL Pierotti, MC Tanzer, AV Jacobsen… - ACS Chemical …, 2020 - ACS Publications
Necroptosis is an inflammatory form of programmed cell death that has been implicated in
various human diseases. Compound 2 is a more potent analogue of the published …

Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury

S Martens, M Jeong, W Tonnus, F Feldmann… - Cell death & …, 2017 - nature.com
Necroptosis contributes to the pathophysiology of several inflammatory, infectious and
degenerative disorders. TNF-induced necroptosis involves activation of the receptor …

[HTML][HTML] Necroptosis in inflammatory bowel disease and other intestinal diseases

S Li, LG Ning, XH Lou, GQ Xu - World journal of clinical cases, 2018 - ncbi.nlm.nih.gov
For a long time, it was believed that apoptosis and necrosis were the main pathways for cell
death, but a growing body of research has shown that there are other pathways. Among …

6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury

C Delehouzé, S Leverrier-Penna, F Le Cann… - Scientific reports, 2017 - nature.com
Necroptosis is a programmed cell death pathway that has been shown to be of central
pathophysiological relevance in multiple disorders (hepatitis, brain and cardiac ischemia …

Necroptosis in CNS diseases: Focus on astrocytes

EV Mitroshina, M Saviuk, MV Vedunova - Frontiers in Aging …, 2023 - frontiersin.org
In the last few years, necroptosis, a recently described type of cell death, has been reported
to play an important role in the development of various brain pathologies. Necroptosis is a …

Necroptosis in heart disease: Molecular mechanisms and therapeutic implications

X Guo, Y Chen, Q Liu - Journal of molecular and cellular cardiology, 2022 - Elsevier
Cell death is a crucial event underlying cardiac ischemic injury, pathological remodeling,
and heart failure. Unlike apoptosis, necrosis had long been regarded as a passive and …

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

AV Jacobsen, CL Pierotti, KN Lowes, AE Au… - Cell Death & …, 2022 - nature.com
Necroptosis is a form of caspase-independent programmed cell death that arises from
disruption of cell membranes by the mixed lineage kinase domain-like (MLKL) …

The role of necroptosis in ROS-mediated cancer therapies and its promising applications

SK Hsu, WT Chang, IL Lin, YF Chen, NB Padalwar… - Cancers, 2020 - mdpi.com
Over the past decades, promising therapies targeting different signaling pathways have
emerged. Among these pathways, apoptosis has been well investigated and targeted to …

Role of necroptosis in infection‐related, immune‐mediated, and autoimmune skin diseases

L Liu, Z Tang, Y Zeng, Y Liu, L Zhou… - The Journal of …, 2021 - Wiley Online Library
Regulated necrosis, also termed necroptosis, is another programmed cell death depending
on a unique molecular pathway that does not overlap with apoptosis. Tumor necrosis factor …

Regulated necrosis: the expanding network of non-apoptotic cell death pathways

TV Berghe, A Linkermann, S Jouan-Lanhouet… - … reviews Molecular cell …, 2014 - nature.com
Cell death research was revitalized by the understanding that necrosis can occur in a highly
regulated and genetically controlled manner. Although RIPK1 (receptor-interacting protein …